Larson Financial Group’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
AC
VCM
VPM
Larson Financial Group's AVNS Position: Q1 2026 in Review
Larson Financial Group reduced its Avanos Medical (AVNS) stake by 7% in Q1 2026, selling an estimated $431 and leaving 427 shares worth $5.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2509.
Larson Financial Group first reported a position in AVNS in Q4 2018 and has held it in 30 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Larson Financial Group held 427 shares of Avanos Medical worth $5.98K as of Q1 2026.
- Larson Financial Group sold 32 Avanos Medical shares in Q1 2026, an estimated $431.
- Avanos Medical made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2509 holding.
- Larson Financial Group first reported a position in Avanos Medical in Q4 2018 and has held it in 30 quarters since.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.